Paul R. Fonteyne is a director of Apellis Pharmaceuticals Inc.
Person profile
Roles
Address
Boston, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Amylyx Pharmaceuticals, Inc.
7 Jun 24
4
Apellis Pharmaceuticals, Inc.
2 Jan 24
4
Amylyx Pharmaceuticals, Inc.
12 Jun 23
4
Apellis Pharmaceuticals, Inc.
4 Jan 23
4
COVETRUS, INC.
13 Oct 22
4
COVETRUS, INC.
6 Jul 22
4
Amylyx Pharmaceuticals, Inc.
10 Jun 22
4
COVETRUS, INC.
13 May 22
4
GELESIS HOLDINGS, INC.
9 May 22
3
GELESIS HOLDINGS, INC.
24 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 24 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.76 | 25,000 | 44.00 k | 25,000 |
1 Jan 24 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,341 | 0.00 | 16,438 |
1 Jan 24 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 59.86 | 5,748 | 344.08 k | 5,748 |
8 Jun 23 | AMLX Amylyx Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 26.25 | 16,985 | 445.86 k | 16,985 |
1 Jan 23 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,867 | 0.00 | 13,097 |
1 Jan 23 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 51.71 | 7,441 | 384.77 k | 7,441 |